Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases - Test2 - elhamkhani - TriplyDB

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

http://www.wikidata.org/entity/Q27009984

about

Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases Importance of Apolipoprotein A-I in Multiple Sclerosis Oxysterols in the pathogenesis of major chronic diseases Cholesterol balance in prion diseases and Alzheimer's disease Haptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines.A protocol for evaluation of Rett Syndrome symptom improvement by metabolic modulators in Mecp2-mutant mice.A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome.TRAP-seq Profiling and RNAi-Based Genetic Screens Identify Conserved Glial Genes Required for Adult Drosophila Behavior.Brain region mapping using global metabolomics.The Impact of Lipoproteins on Wound Healing: Topical HDL Therapy Corrects Delayed Wound Healing in Apolipoprotein E Deficient Mice.Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice Cholesterol in the Pathogenesis of Alzheimer's, Parkinson's Diseases and Autism: Link to Synaptic Dysfunction Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population.Reduced right frontal fractional anisotropy correlated with early elevated plasma LDL levels in obese young adults MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.Cholesterol in brain disease: sometimes determinant and frequently implicated.Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann-Pick C1, Alzheimer's disease, and atherosclerosis.Targeting cholesterol homeostasis to fight hearing loss: a new perspective.The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of sphingolipid metabolism Relationship between Concentrations of Lutein and StARD3 among Pediatric and Geriatric Human Brain Tissue.Delivery of the 7-dehydrocholesterol reductase gene to the central nervous system using adeno-associated virus vector in a mouse model of Smith-Lemli-Opitz Syndrome.Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism.Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model Heart disease as a risk factor for dementia.Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study.Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk.Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Lipid rafts in neurodegeneration and neuroprotection.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Cholesterol and metal ions in Alzheimer's disease.Complex lipid trafficking in Niemann-Pick disease type C.GM1 Ganglioside: Past Studies and Future Potential.Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Embryonic exposure to 10 μg L(-1) lead results in female-specific expression changes in genes associated with nervous system development and function and Alzheimer's disease in aged adult zebrafish brain.Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

P2860

Q26771260-B9D00347-EF5A-47FC-B8D9-60AA68D323C1 Q26774272-D902747D-D133-40C2-9669-952E0743513C Q26774792-52613307-10A0-45A8-898F-23F68C276F33 Q26864594-29F974CF-B55B-4D42-B2A8-4F0107E51AF9 Q27002948-7500E845-8615-4FB2-B19C-7BDC3D742FB2 Q29346953-A63F1873-0139-4936-A7F9-C3E570D6D690 Q30422702-06548588-D2CE-40F4-BF7E-E208AC3B531E Q30442429-7E27A901-E62D-41A2-AC21-37BC51508F4F Q30832725-DD0823E5-5E50-4772-9A3C-55A097684456 Q30873368-BF152CDE-EC07-4FE8-8594-64BA939154AB Q33584728-411173B9-02CD-4C61-B079-0947331011DF Q33588229-3F8DE358-6805-46A0-9FC7-85B31133EA82 Q33607803-9FFD72FD-272C-4065-8781-F4CC48F1807E Q33763342-0C02E0DE-1203-4BDB-9706-DFE99D86E17E Q33895412-886DBA62-DEE4-45E6-B8DD-0790AA4EA2AD Q34287178-F68AA2BD-E8EA-473E-8B90-DC2351C743EC Q34613640-0E53E369-C397-4300-B4D5-36ABF814263A Q34621446-6067B97C-B597-460E-9227-B2AB79C88367 Q34673948-63435B56-59AD-4300-BE6A-AED26225C9A4 Q35025997-D6B63E74-758A-4129-A8C6-88E8ABE07B13 Q35624096-B519F3D8-C34D-438C-B0BA-24E78FE20F9D Q36024157-A21EA9B2-5D79-4F4C-A5EF-B30E26F2A4EC Q36024854-A0F2E092-9A1C-465A-A5F9-1D2099C91891 Q36199829-13342ACB-366D-4DF1-B550-BA77A18E654C Q36428502-62D6183E-D6EF-457B-9577-4416C5FD7C3B Q36811092-C0BD6103-5B8E-4062-9BEE-A705D3B4A967 Q36913723-C9B095A2-C8AD-408C-800A-A1D7713EBA33 Q37058206-5295BCD5-CE79-4745-9F6C-BC7180693901 Q37153998-20C9685E-1B0E-48D3-BB17-781119F31C50 Q37734257-B501DDDE-D6DB-4665-8865-B299F5289836 Q38173298-58514826-9696-4ED0-B733-90F2D8E1C7AF Q38179262-D085A43E-D9AC-4BE8-B800-26C8C5481E59 Q38202852-8EAF57AF-567F-4975-AEE7-31DBC7D64BC0 Q38271491-69A8EB85-F970-4E3B-92EC-B4FA7B3E2C57 Q38374343-4E0AD3DF-40AB-40CD-B303-0961EC0E159A Q38414035-EB3414AF-F80D-4BAB-B128-14769D64499B Q38452294-47335DF5-5008-4143-8B35-F038EBDAF4D3 Q38598430-51DE5178-3EA3-4AAF-AF50-166EDD456920 Q38663090-9969CA53-7D4C-4F9B-855E-857D01E81A9B Q38664298-32FD71AF-E231-498B-B84C-3DACD349AED7

P2860

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

http://www.wikidata.org/entity/Q27009984

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@ast

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@en

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@nl

type

label

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@ast

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@en

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@nl

prefLabel

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@ast

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@en

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@nl

P1433

Q27009984-F63B0310-B4A5-4AB5-87F7-3490F3E88F0D

P1476

Q27009984-DB1A20F2-74A5-46DF-8FA0-E5C17FF7457B

P2093

Q27009984-207E72DF-BB64-4157-AAF2-2EC96FD1F536

P2860

Q27009984-0225D251-C9FC-4566-A4AD-E9067D558BD3

Q27009984-0584C5C9-5AAA-4888-9CF9-11E49BE3B491

Q27009984-069DD3F1-9DFD-4C95-9927-E1E606F05F95

Q27009984-06B384A3-D6D8-469D-8AA3-6B075C16A9CF

Q27009984-06BDF27C-1BE5-42D8-B357-AB42CA0573D4

Q27009984-0A04CF8F-8A58-4B0B-B7FC-66744EF2E0B5

Q27009984-0CA35CEB-8AAA-40C6-84B6-EE9AF6359169

Q27009984-0E1B75AF-07AA-459A-8EA4-4B7150FF0E2B

Q27009984-0EAC7CB4-C34A-4D19-AACC-812DC688B552

Q27009984-10696CEC-934D-41E3-9DA9-0FF4A4103F2D

P304

Q27009984-883D5C4E-6D6D-4C51-9C4C-03B2BD8C4D0F

P31

Q27009984-AF1BD934-34D5-4171-A5BF-77E11942A161

Q27009984-FD73E76B-AB51-4045-A1E5-EC77D4308B71

P3181

Q27009984-D6F869FF-1364-4873-9B9E-20F373DE4589

P356

Q27009984-A994A248-9237-4ECE-8B17-7EC9A80815B5

P407

Q27009984-E86E83A7-8DD0-4B0E-89CA-376082A4ECC1

P433

Q27009984-D35B8653-E8E7-4026-A389-CDF2378F97F5

P478

Q27009984-B9F17D50-1518-4081-B715-CE328F6976F1

P577

Q27009984-54836D7A-CB38-4FFC-AB1B-AAB301E06EE7

Q27009984-5D843D82-6B32-491E-82F3-BAC65F5A7312

P5875

Q27009984-D058C1CA-7343-49A9-81EF-A1A35803DD66

P698

Q27009984-47CFB188-B2CE-47CE-9564-57C8C88B0232

P921

Q27009984-2A4EDD8B-D80C-4053-A1FD-FF5D0634C15D

Q27009984-753B6A71-FAE1-4FD1-B9AC-F81D83AC3D43

Q27009984-85182892-A9B8-4495-8089-8CF5663B8341

Q27009984-D496AD5B-1F6F-4E4E-93D8-DA3575F687A5

Q27009984-EC6E73CB-5B62-49F3-B820-4FC66C38B4BA

P932

Q27009984-121C9AD1-ABD7-4F38-9C19-A4625331B5E2

P3181

P356

P1433

Disease Models & Mechanisms

P1476

Dysregulation of cholesterol b ...... to neurodegenerative diseases

@en

P2093

J. E. Vance

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain

Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts

Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization

The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Functions of lipoprotein receptors in neurons

The LDL receptor gene family: (un)expected signal transducers in the brain

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

P304

746-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1483586

http://www.w3.org/2001/XMLSchema#string

P356

10.1242/DMM.010124

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232248042

http://www.w3.org/2001/XMLSchema#string

P698

23065638

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

polycyclic compound

P932

3484857

http://www.w3.org/2001/XMLSchema#string